Friday, July 10, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “pioglitazone” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 42
Total indexed 20,548
Sponsors 1,771

Quick answer

Showing 42 pipeline programs matching "pioglitazone" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

42 results for “pioglitazone” Back to intelligence hub

Search results

Page 2 of 2
  1. Pioglitazone

    Takeda

    Bone Metabolism

    approved small molecule completed

    1 trial
  2. Pioglitazone

    Takeda

    Diabetes Mellitus

    approved small molecule completed

    9 trials
  3. Pioglitazone

    Takeda

    Diabetes Mellitus, Type 2

    approved small molecule completed

    2 trials
  4. Pioglitazone

    Takeda

    Diabetes Type 2

    approved small molecule completed

    1 trial
  5. Pioglitazone

    Takeda

    Metabolic Syndrome

    approved small molecule completed

    1 trial
  6. Pioglitazone

    Takeda

    Obesity

    approved small molecule completed

    1 trial
  7. Pioglitazone 15mg

    United Therapeutics Europe Ltd

    High Altitude

    approved small molecule completed

    1 trial
  8. Pioglitazone 15mg

    Takeda

    Inflammation

    approved small molecule completed

    1 trial
  9. Pioglitazone and Metformin

    Disc Medicine

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial
  10. Pioglitazone and insulin

    Takeda

    Diabetes Mellitus

    approved small molecule completed

    2 trials
  11. Pioglitazone and metformin

    Takeda

    Diabetes Mellitus

    approved small molecule completed

    5 trials
  12. Pioglitazone then Placebo

    Takeda

    Diabetes

    approved small molecule completed

    1 trial
  13. alogliptin+pioglitazone

    Takeda

    Diabetes Mellitus, Type 2

    approved small molecule terminated

    1 trial
  14. pioglitazone

    GlaxoSmithKline

    Diabetes Mellitus, Type 2

    approved small molecule terminated

    1 trial
  15. pioglitazone

    Takeda

    Type 2 Diabetes Mellitus

    approved small molecule completed

    4 trials
  16. pioglitazone

    Takeda

    Type 2 Diabetes

    approved small molecule completed

    1 trial
  17. Pioglitazone

    Takeda

    Uric Acid Kidney Stone Disease

    small molecule completed

    1 trial
  18. Pioglitazone

    Takeda

    HIV Infections

    small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.